Eric Lefkofsky has become one of the most prominent entrepreneurs in Chicago. He came to the attention of the business community as the co-founder of Groupon. In 2010, Forbes reported that Groupon was the fastest growing company in history. In 2011, Groupons Initial Purchase Offer was the largest for a United States internet based company since Google. With the success of Groupon, Lefkofsky has had the privilege of using his knowledge to focus on the things that are most important to him.
Eric Lefkofsky has gone on to be a founding partner in Lightbank, a venture capital company that focuses on business upstarts in the Chicago area. Lightbank is one of his ways of giving back to the local community. Lefkofsky also is the co-founder of Uptake, an organization that focuses on industry analytics. He also is the co-founder of Mediaocean, Echo Global Logistics and InnerWorkings. When he sees a good idea, Erik Lefkofsky is there to help see that these businesses reach their full potential.
Tempus is the latest venture for Erik Lefkofsky. Tempus is a technology company that is establishing an information infrastructure to help in the battle against cancer. Tempus is a new company that just recently opened for business in 2015. It has now grown into a 200 person company and is one of Chicago’s top ten technology startups. Lefkofsky feels that information technology has not caught up with cancer treatment and he wants to be the one that changes this situation.
The open exchange of the most advanced cancer research, treatments and advancements is the goal of everyone involved with Tempus. One of the latest medical technologies incorporated into modern cancer treatment is gene sequencing. Tempus offers patients highly advanced tests for gene sequencing at its laboratory, and also provides oncologist the software to quickly compare a patients genetic profile to a vast database of other cancer patients. Tempus gives doctors the most advanced information in one easy to access platform.
Erik Lefkofsky and Tempus have taken on the challenge of helping to battle cancer. The more information that is available to doctors is one of the ways of ultimately finding a cure.